Every seasoned investor knows that market shocks are inevitable, but few are prepared for the specific depth of the hit. Historically, across 15 major crises, Lowe's (NYSE: LOW) absorbs an average drawdown of 18% compared to the S&P 500’s average decline of 16%. While the stock often tracks the broader market, certain economic fractures trigger a much steeper trapdoor effect that catches retail in...
Every seasoned investor knows that market shocks are inevitable, but few are prepared for the specific depth of the hit. Historically, across 15 major crises, Lowe's (NYSE: LOW) absorbs an average drawdown of 18% compared to the S&P 500’s average decline of 16%. While the stock often tracks the broader market, certain economic fractures trigger a much steeper trapdoor effect that catches retail investors off guard.
Investing.com -- KeyBanc Capital Markets is growing increasingly wary of Apple shares, saying the stock's valuation is "stretched" and that proprietary spending data points to "initial cracks in the bulls' multi-year compounding growth view" as U.S. hardware demand reverts toward normal seasonality.
Investing.com -- KeyBanc Capital Markets is growing increasingly wary of Apple shares, saying the stock's valuation is "stretched" and that proprietary spending data points to "initial cracks in the bulls' multi-year compounding growth view" as U.S. hardware demand reverts toward normal seasonality.
Hi, it’s Pei Li, Elffie Chew and Manuel Baigorri, taking a look at the boom in data center deals in Asia. Also today, a major takeover bid in the UK food sector. Today’s top stories AI chipmaker Cerebras raises $5.6 billion in year’s biggest IPO . Tate & Lyle gets up to £2.7 billion takeover bid from Ingredion. Japan’s Eneos buys Chevron Asia oil assets for $2.2 billion. Ronaldo expands into strea...
Hi, it’s Pei Li, Elffie Chew and Manuel Baigorri, taking a look at the boom in data center deals in Asia. Also today, a major takeover bid in the UK food sector. Today’s top stories AI chipmaker Cerebras raises $5.6 billion in year’s biggest IPO . Tate & Lyle gets up to £2.7 billion takeover bid from Ingredion. Japan’s Eneos buys Chevron Asia oil assets for $2.2 billion. Ronaldo expands into streaming with LiveModeTV stake. Buyout titans bet Middle East’s long-term appeal remains intact. Powered up Data centers are at the forefront of dealmaking in Asia as global funds seek a foothold in a sector riding high on the rapid adoption of AI. “There is an acceleration of demand in Asia Pacific data centers, resulting in large-scale orders from both Western and Asian hyperscalers,” said Axel Granger , co-head of TMT in the region at UBS. One of the biggest platforms is DayOne, which we reported Thursday is looking to upsize its latest funding round to $4 billion on the back of strong international interest. A day before, companies linked to the world’s biggest battery maker, China’s CATL, agreed to buy as much as 38% of data center operator VNET, in a deal that could be valued at nearly $1 billion. Data center campuses have grown to about 500 megawatts from 50-100 a few years ago, according to Granger, who says “private capital may not be sufficient” to support the expansion. That being the case, he expects some consolidation among data center platforms and more IPOs. We wrote in early February about the excitement around digital infrastructure in Asia, and it is proving pretty relentless, with a wave of transactions on the horizon. Blue Owl Capital’s Stack Infrastructure is considering a sale of its data center assets in Australia, Japan and Malaysia in a transaction that may be valued at over $30 billion. Digital Edge , Bridge Data Centres , Princeton Digital Group, Telkom Indonesia are also working on or considering multi-billion dollar deals . Moody’s expects at least ...
MADRID and CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the three months ended March 31, 2026, and provided a corporate update on recent developments.
MADRID and CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the three months ended March 31, 2026, and provided a corporate update on recent developments.
Wheat is mostly lower early on Thursday morning. The wheat complex followed Tuesday’s limit gains with the three exchanges lower on Wednesday. Chicago SRW futures closed with contracts steady to 3 ½ cents lower. Open interest was up 3,742 contracts. KC HRW futures were down 4 ¾ to 7 ¾...
Wheat is mostly lower early on Thursday morning. The wheat complex followed Tuesday’s limit gains with the three exchanges lower on Wednesday. Chicago SRW futures closed with contracts steady to 3 ½ cents lower. Open interest was up 3,742 contracts. KC HRW futures were down 4 ¾ to 7 ¾...